ELI LILLY & Co — Director's Dealing 2014

Sep 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-09-08

Reporting Person: Ricks David A (SVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-08	Common Stock	M	1509	$55.65	Acquired	35593	Direct
2014-09-08	Common Stock	F	1353	$64.72	Disposed	34240	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-08	Employee stock option 2/05 (right to buy)	$55.65	M	1509	Disposed	2015-02-10	Common Stock (1509.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3459	Indirect